Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)

ClinicalTrials.gov ID: NCT03940196

Public ClinicalTrials.gov record NCT03940196. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ENGOT-ov50 / GOG-3029 / INNOVATE-3: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of Tumor Treating Fields (TTFields) concomitant with weekly paclitaxel for the treatment of recurrent ovarian cancer . The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the malignant tumor, by means of surface, insulated electrode arrays.

Study identification

NCT ID
NCT03940196
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NovoCure Ltd.
Industry
Enrollment
540 participants

Conditions and interventions

Conditions

Interventions

Device · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2019 (Actual)
Primary completion
May 18, 2023 (Actual)
Completion
May 18, 2023 (Actual)
Last update posted
Mar 29, 2024

2019 – 2023

United States locations

U.S. sites
59
U.S. states
24
U.S. cities
53
Facility City State ZIP Site status
Arizona Oncology- Biltmore Cancer Center Phoenix Arizona 85016 —
Arizona Oncology Tucson Arizona 85711 —
University of California La Jolla California 92093-1503 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
California Pacific Medical Center- Pacific Campus San Francisco California 94109 —
Olive View - UCLA Medical Center Sylmar California 91342 —
Rocky Mountain Cancer Centers Aurora Colorado 80012 —
University of Colorado Denver Aurora Colorado 80045-2517 —
Rocky Mountain Cancer Centers Boulder Colorado 80303 —
Rocky Mountain Cancer Centers Colorado Springs Colorado 80907 —
Rocky Mountain Cancer Centers Denver Colorado 80218 —
Rocky Mountain Cancer Centers Denver Colorado 80220 —
Rocky Mountain Cancer Centers Lakewood Colorado 80228 —
Rocky Mountain Cancer Centers Littleton Colorado 80120-4413 —
Rocky Mountain Cancer Centers Lone Tree Colorado 80124 —
Rocky Mountain Cancer Centers Longmont Colorado 80501 —
Rocky Mountain Cancer Centers Parker Colorado 80138 —
Rocky Mountain Cancer Centers Pueblo Colorado 81008 —
Rocky Mountain Cancer Centers Thornton Colorado 80260 —
Broward Health Medical Center Fort Lauderdale Florida 33316 —
AdventHealth Cancer Institute Orlando Florida 32804 —
Northeast Georgia Medical Center Gainesville Georgia 30501 —
Rush University Cancer Center - Chicago and Innovation Chicago Illinois 60612-3833 —
Des Moines Oncology Research Association Des Moines Iowa 50309 —
Norton Cancer Institute Louisville Kentucky 40202-2025 —
Maryland Oncology Hematology, P.A. Silver Spring Maryland 20902 —
Lahey Hospital & Medical Center Burlington Massachusetts 01805 —
Minnesota Oncology Hematology, PA Saint Paul Minnesota 55102 —
Washington University School of Medicine in St. Louis St Louis Missouri 63110-1010 —
Methodist Estabrook Cancer Center Omaha Nebraska 68114-4108 —
Women's Cancer Center of Nevada Las Vegas Nevada 89169 —
Center of Hope at Renown Medical Center Reno Nevada 89502 —
MD Anderson Cancer Center at Cooper Camden New Jersey 08103 —
The Valley Hospital Paramus New Jersey 07652 —
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157 —
Miami Valley Hospital South Centerville Ohio 45459-447 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210-1240 —
Northwest Cancer Specialists, PC Portland Oregon 97227 —
West Penn OB/GYN Pittsburgh Pennsylvania 15212 —
UPMC Cancer Center Pittsburgh Pennsylvania 15232 —
Abington Hospital- Asplundh Cancer Pavilion Willow Grove Pennsylvania 19001-3720 —
Women & Infants Hospital of Rhode Island Providence Rhode Island 02905-2401 —
Sanford Gynecologic Oncology Clinic Sioux Falls South Dakota 57104 —
Texas Oncology Austin-Balcones Austin Texas 78731 —
Texas Oncology Austin-Midtown Austin Texas 78745 —
Texas Oncology Austin-North Austin Austin Texas 78758 —
University of Texas Southwestern Medical Center Dallas Texas 75216 —
Texas Oncology Dallas Texas 75246 —
Texas Oncology-Fort Worth Fort Worth Texas 76104-2150 —
The University of Texas Medical School at Houston Houston Texas 77030-1501 —
Texas Oncology-McAllen McAllen Texas 78503 —
Texas Oncology San Antonio Medical Center San Antonio Texas 78240 —
Texas Oncology - Sugar Land Sugar Land Texas 77479-4308 —
Texas Oncology The Woodlands Texas 77380 —
Texas Oncology-Tyler Tyler Texas 75702 —
Texas Oncology-Deke Slayton Cancer Center Webster Texas 77598 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Carilion Clinic-Gynecologic Oncology Roanoke Virginia 24016-4962 —
Multicare Institute for Research and Innovation Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03940196, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2024 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03940196 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →